Compounds > n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine
Page last updated: 2024-09-03

n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine and Fasciola Infection

n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine has been researched along with Fasciola Infection in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alberti-Navarro, A; Alcala-Canto, Y; Gracia-Mora, J; Ibarra-Velarde, F; Sumano-Lopez, H1

Trials

1 trial(s) available for n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine and Fasciola Infection

ArticleYear
Effect of a cysteine protease inhibitor on Fasciola hepatica (liver fluke) fecundity, egg viability, parasite burden, and size in experimentally infected sheep.
    Parasitology research, 2007, Volume: 100, Issue:3

    Topics: Animals; Cysteine Proteinase Inhibitors; Fasciola hepatica; Fascioliasis; Fertility; Leucine; Ovum; Sheep; Sheep Diseases

2007